Preoperative Treatment With Cetuximab and/or IMC-A12

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00957853
Recruitment Status : Active, not recruiting
First Posted : August 13, 2009
Last Update Posted : August 18, 2017
ImClone LLC
Eli Lilly and Company
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : October 2018